Mutagenicity of heterocyclic amines when activated by pancreas tissue

Terence A Lawson, Carol Kolar

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The heterocyclic amines (HA) 2-aminodipyridol[1,2-a:3′2-d]imidazole (Glu-P-2), 2-amino-3,4-dimethylimidazo- [4,5-f]quinoline (MeIQ) and 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) were mutagenic in V79 cells (Chinese hamster lung fibrobalsts) using 6-thioguanine resistance as the marker of mutagenicity. Pancreas duct epithelial cells (DEC) from untreated hamsters, homogenates of pancreas ducts from untreated hamsters and those fed a high fat diet and human DEC were used to activate the heterocyclic amines. When hamster cells and tissues were used the optimum mutation frequencies ( mutants/106 survivors) measured were: Glu-P-2, 10±1; MeIQ, 28±2 (DEC), 12±2 (control, duct homogenate, and 21±2 (high fat diet fed, duct homogenate); PhIP, 61±5. When human DEC were used the optimum mutation frequencies were: MeIQ, 32±4; PhIP, 35±3.3,8-Dimethylimidazo[4,5-f]quinoxaline, 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]dole and 3-amino-1-methyl-5H-pyridol[4,3-b]indole were not mutagenic in this assay.

Original languageEnglish (US)
Pages (from-to)125-128
Number of pages4
JournalMutation Research Letters
Volume325
Issue number4
DOIs
StatePublished - Jan 1 1994

Fingerprint

2-amino-3,4-dimethylimidazo(4,5-f)quinoline
Ducts
Amines
Pancreas
Cricetulus
Cricetinae
Tissue
Epithelial Cells
High Fat Diet
Mutation Rate
Lung
Thioguanine
Quinoxalines
Nutrition
Fats
Assays

Keywords

  • Hamster
  • Heterocyclic amines
  • Human
  • Mutagenicity
  • Pancreas duct epithelium
  • V79 cells

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mutagenicity of heterocyclic amines when activated by pancreas tissue. / Lawson, Terence A; Kolar, Carol.

In: Mutation Research Letters, Vol. 325, No. 4, 01.01.1994, p. 125-128.

Research output: Contribution to journalArticle

Lawson, Terence A ; Kolar, Carol. / Mutagenicity of heterocyclic amines when activated by pancreas tissue. In: Mutation Research Letters. 1994 ; Vol. 325, No. 4. pp. 125-128.
@article{2522686b382c4b489041ff0e34b2fddf,
title = "Mutagenicity of heterocyclic amines when activated by pancreas tissue",
abstract = "The heterocyclic amines (HA) 2-aminodipyridol[1,2-a:3′2-d]imidazole (Glu-P-2), 2-amino-3,4-dimethylimidazo- [4,5-f]quinoline (MeIQ) and 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) were mutagenic in V79 cells (Chinese hamster lung fibrobalsts) using 6-thioguanine resistance as the marker of mutagenicity. Pancreas duct epithelial cells (DEC) from untreated hamsters, homogenates of pancreas ducts from untreated hamsters and those fed a high fat diet and human DEC were used to activate the heterocyclic amines. When hamster cells and tissues were used the optimum mutation frequencies ( mutants/106 survivors) measured were: Glu-P-2, 10±1; MeIQ, 28±2 (DEC), 12±2 (control, duct homogenate, and 21±2 (high fat diet fed, duct homogenate); PhIP, 61±5. When human DEC were used the optimum mutation frequencies were: MeIQ, 32±4; PhIP, 35±3.3,8-Dimethylimidazo[4,5-f]quinoxaline, 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]dole and 3-amino-1-methyl-5H-pyridol[4,3-b]indole were not mutagenic in this assay.",
keywords = "Hamster, Heterocyclic amines, Human, Mutagenicity, Pancreas duct epithelium, V79 cells",
author = "Lawson, {Terence A} and Carol Kolar",
year = "1994",
month = "1",
day = "1",
doi = "10.1016/0165-7992(94)90074-4",
language = "English (US)",
volume = "325",
pages = "125--128",
journal = "Mutation Research Letters",
issn = "0165-7992",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Mutagenicity of heterocyclic amines when activated by pancreas tissue

AU - Lawson, Terence A

AU - Kolar, Carol

PY - 1994/1/1

Y1 - 1994/1/1

N2 - The heterocyclic amines (HA) 2-aminodipyridol[1,2-a:3′2-d]imidazole (Glu-P-2), 2-amino-3,4-dimethylimidazo- [4,5-f]quinoline (MeIQ) and 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) were mutagenic in V79 cells (Chinese hamster lung fibrobalsts) using 6-thioguanine resistance as the marker of mutagenicity. Pancreas duct epithelial cells (DEC) from untreated hamsters, homogenates of pancreas ducts from untreated hamsters and those fed a high fat diet and human DEC were used to activate the heterocyclic amines. When hamster cells and tissues were used the optimum mutation frequencies ( mutants/106 survivors) measured were: Glu-P-2, 10±1; MeIQ, 28±2 (DEC), 12±2 (control, duct homogenate, and 21±2 (high fat diet fed, duct homogenate); PhIP, 61±5. When human DEC were used the optimum mutation frequencies were: MeIQ, 32±4; PhIP, 35±3.3,8-Dimethylimidazo[4,5-f]quinoxaline, 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]dole and 3-amino-1-methyl-5H-pyridol[4,3-b]indole were not mutagenic in this assay.

AB - The heterocyclic amines (HA) 2-aminodipyridol[1,2-a:3′2-d]imidazole (Glu-P-2), 2-amino-3,4-dimethylimidazo- [4,5-f]quinoline (MeIQ) and 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) were mutagenic in V79 cells (Chinese hamster lung fibrobalsts) using 6-thioguanine resistance as the marker of mutagenicity. Pancreas duct epithelial cells (DEC) from untreated hamsters, homogenates of pancreas ducts from untreated hamsters and those fed a high fat diet and human DEC were used to activate the heterocyclic amines. When hamster cells and tissues were used the optimum mutation frequencies ( mutants/106 survivors) measured were: Glu-P-2, 10±1; MeIQ, 28±2 (DEC), 12±2 (control, duct homogenate, and 21±2 (high fat diet fed, duct homogenate); PhIP, 61±5. When human DEC were used the optimum mutation frequencies were: MeIQ, 32±4; PhIP, 35±3.3,8-Dimethylimidazo[4,5-f]quinoxaline, 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]dole and 3-amino-1-methyl-5H-pyridol[4,3-b]indole were not mutagenic in this assay.

KW - Hamster

KW - Heterocyclic amines

KW - Human

KW - Mutagenicity

KW - Pancreas duct epithelium

KW - V79 cells

UR - http://www.scopus.com/inward/record.url?scp=0028170836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028170836&partnerID=8YFLogxK

U2 - 10.1016/0165-7992(94)90074-4

DO - 10.1016/0165-7992(94)90074-4

M3 - Article

VL - 325

SP - 125

EP - 128

JO - Mutation Research Letters

JF - Mutation Research Letters

SN - 0165-7992

IS - 4

ER -